Atlas Trials

Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis

Clinical trial NCT05180500 · COMPLETED

Trial details

NCT number
NCT05180500
Sponsor
Sharon Hillier
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19PharmacokineticsSafety
Start date
2022-03-15
Primary completion
2022-12-07
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.